Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity. More information...
According to PR-model, seattlegenetics.com is ranked 244,628th in multilingual Wikipedia, in particular this website is ranked 132,481st in English Wikipedia.
The website is placed before jamalnow.com and after assemblee-nationale.sn in the BestRef global ranking of the most important sources of Wikipedia.
